1. A statement of intellectual property policies.

  2. When appropriate, creation of a clear Material Transfer Agreement or user agreement.

  3. A liability statement.

  4. A system for disposal of material.

(e) Clear criteria for distribution of cell lines, including but not limited to evidence of approval of the research by an Embryonic Stem Cell Research Oversight committee or equivalent body at the recipient institution.



The National Academies | 500 Fifth St. N.W. | Washington, D.C. 20001
Copyright © National Academy of Sciences. All rights reserved.
Terms of Use and Privacy Statement